Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
Nuwellis, Inc. announced a strategic commercial agreement with Atrility Medical to co-promote and distribute the FDA-cleared AtriAmp® device, expanding its pediatric and critical care portfolio. The initial six-month co-promotion program in select U.S. territories aims to leverage Nuwellis' commercial infrastructure to accelerate adoption and broad…